Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017)

Market Cap	7.97B
Revenue (ttm)	3.03B
Net Income (ttm)	299.74M
Shares Out	230.00M
EPS (ttm)	1.30
PE Ratio	26.59
Forward PE	23.42
Dividend	0.30 (0.87%)
Ex-Dividend Date	n/a

Volume	142,747
Average Volume	190,939
Open	34.50
Previous Close	34.66
Day's Range	33.68 - 34.60
52-Week Range	33.72 - 70.90
Beta	n/a
RSI	27.36
Earnings Date	Mar 11, 2026

About TADAWUL:4017

Dr. Soliman Abdel Kader Fakeeh Hospital Company, together with its subsidiaries, establishes, operates, and manages hospitals, clinics, medical, educational, and training centers in the Kingdom of Saudi Arabia. It operates through Medical Services; Education; and Trading, Retail & Others segments. The company offers various services, such as assisted reproductive therapy, audiology, bariatric surgery, pediatric, breast feeding, cardiac surgery, cardiology, chest and respiratory diseases, chiropractic medicine, dental and maxillofacial, dermatol...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1978
• Employees: 2,672
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4017

Financial Performance

In 2024, TADAWUL:4017's revenue was 2.79 billion, an increase of 19.95% compared to the previous year's 2.33 billion. Earnings were 287.55 million, an increase of 2.85%.